Translocated in Liposarcoma (TLS), also known as Fused in Sarcoma (FUS), is a multifunctional RNA-binding protein implicated in neurodegenerative diseases due to its tendency to aggregate. While mutations in TLS are linked to familial amyotrophic lateral sclerosis (ALS), approximately 90% of ALS cases are sporadic with no known genetic mutations. In these instances, pathological aggregation of wild-type TLS is believed to play a critical role, although the molecular triggers remain elusive. RNA is known to modulate TLS phase separation, but the features that drive RNA-induced precipitation are poorly understood. Here, we report that synthetic PolyG RNA robustly induces both phase separation and irreversible precipitation of recombinant TLS in vitro. This effect is concentration-dependent and strongly influenced by RNA sequence composition. Specifically, guanine-rich RNAs such as PolyG promote aggregation, whereas uridine-rich RNAs fail to induce precipitation and may even inhibit it. These findings suggest a selective interaction between TLS and G-rich RNA sequences. Notably, the resulting TLS-RNA complexes undergo precipitation in a manner distinct from classical liquid-liquid phase separation, highlighting a unique mechanism of RNA-induced protein misfolding. Through detailed molecular biological and biochemical analyses, we further demonstrate that PolyG-induced condensates transition into solid-like aggregates over time. Our results uncover a previously uncharacterized pathway of RNA-mediated TLS aggregation and suggest that guanine-rich RNAs may contribute to pathological protein misfolding in neurodegenerative disease contexts.
No takes yet. Share an insight, caveat, or question.
Ueda et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: